Lee Ainslie Day One Biopharmaceuticals, Inc. Transaction History
Maverick Capital LTD
- $5.07 Billion
- Q2 2024
A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 1,211,138 shares of DAWN stock, worth $17.5 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
1,211,138
Previous 1,256,570
3.62%
Holding current value
$17.5 Million
Previous $20.8 Million
19.6%
% of portfolio
0.33%
Previous 0.41%
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
166Shares Held
71.9MCall Options Held
163KPut Options Held
183K-
Ra Capital Management, L.P. Boston, MA7.87MShares$114 Million1.63% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$93 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$66.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$65.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$54.7 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.06B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...